| 1 |
34160442 | Clinical safety and outcome of recombinant tissue plasminogen activator in patients with stroke attributable to small artery occlusion: A protocol for systematic review and meta-analysis. | 2021 Jun 25 |
1 |
| 2 |
34808477 | Correlation between the B-type Natriuretic Peptide before thrombolysis and prognosis in patients with ischemic stroke. | 2021 Dec |
1 |
| 3 |
31478148 | Hesperidin reduces adverse symptomatic intracerebral hemorrhage by promoting TGF-β1 for treating ischemic stroke using tissue plasminogen activator. | 2020 Jan |
1 |
| 4 |
33075707 | The Risk Factors for Death within 6 Months After Ischemic Stroke in Patients with Cancer. | 2020 Dec |
1 |
| 5 |
24981554 | A comparison of rt-PA thrombolysis guidelines between China and the USA: are changes needed? | 2015 Jan |
1 |
| 6 |
24926305 | The smoking paradox: impact of smoking on recanalization in the setting of intra-arterial thrombolysis. | 2014 Jan |
1 |
| 7 |
22311232 | Angioedema after tPA: what neurointensivists should know. | 2012 Jun |
1 |
| 8 |
23008384 | Revascularization grading in endovascular acute ischemic stroke therapy. | 2012 Sep 25 |
1 |
| 9 |
11296577 | Baseline computed tomography changes and clinical outcome after thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke. | 2001 Apr |
1 |
| 10 |
11470706 | Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. | 2001 Aug |
1 |
| 11 |
2105879 | [Systemic lysotherapy using recombinant tissue plasminogen activator for fulminant pulmonary embolism]. | 1990 Feb 16 |
1 |
| 12 |
3102144 | A kinetic analysis of fibrinogenolysis during plasminogen activator therapy. | 1987 Mar |
1 |